Page last updated: 2024-11-02

pioglitazone and Autoimmune Disease

pioglitazone has been researched along with Autoimmune Disease in 11 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
" In the present study, we investigated the anti-inflammatory effects of PPAR-γ agonist, pioglitazone, on murine model of endogenous uveitis."7.79Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis. ( Goto, H; Hattori, T; Kezuka, T; Matsuda, R; Nakagawa, H; Okunuki, Y; Tajima, K; Ueda, S; Usui, Y, 2013)
" In the present study, we investigated the anti-inflammatory effects of PPAR-γ agonist, pioglitazone, on murine model of endogenous uveitis."3.79Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis. ( Goto, H; Hattori, T; Kezuka, T; Matsuda, R; Nakagawa, H; Okunuki, Y; Tajima, K; Ueda, S; Usui, Y, 2013)
"As rosiglitazone has recently been linked to a higher risk of heart failure, stroke, and all-cause mortality in old patients, it has been interrupted from the European market."2.50Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines. ( Antonelli, A; Di Domenicantonio, A; Fallahi, P; Ferrari, SM; Ferri, C; Manfredi, A, 2014)
" Then the rats were divided into 3 groups of 9 rats: PPAR-gamma ligand 15-deoxy-(12,14)-PGJ(2) (15d-PGJ(2)) group (15d-PGJ(2) was injected intraperitoneally at the dosage of 200 microg."1.32[Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity]. ( Kishimoto, C; Liu, Y; Liu, ZQ; Yuan, ZY; Zhang, JJ, 2003)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Fauber, BP1
Gobbi, A1
Robarge, K1
Zhou, A1
Barnard, A1
Cao, J1
Deng, Y1
Eidenschenk, C1
Everett, C1
Ganguli, A1
Hawkins, J1
Johnson, AR1
La, H1
Norman, M1
Salmon, G1
Summerhill, S1
Ouyang, W1
Tang, W1
Wong, H1
Kim, HJ1
Jeong, IK1
Hur, KY1
Kim, SK1
Noh, JH1
Chun, SW1
Kang, ES1
Rhee, EJ1
Choi, SH1
Vis, DC1
Kelly, MM1
De Heuvel, E1
MacEachern, PR1
Yamada, T1
Hiraoka, E1
Miyazaki, T1
Sato, J1
Ban, N1
Okunuki, Y1
Usui, Y1
Nakagawa, H1
Tajima, K1
Matsuda, R1
Ueda, S1
Hattori, T1
Kezuka, T1
Goto, H1
Ferrari, SM1
Antonelli, A1
Di Domenicantonio, A1
Manfredi, A1
Ferri, C1
Fallahi, P1
Yuan, Z3
Liu, Y8
Zhang, J3
Kishimoto, C4
Wang, Y2
Ma, A3
Liu, Z3
Yuan, ZY1
Zhang, JJ1
Liu, ZQ1
Hasegawa, H1
Takano, H1
Zou, Y1
Qin, Y1
Hizukuri, K1
Odaka, K1
Toyozaki, T1
Komuro, I1

Reviews

1 review available for pioglitazone and Autoimmune Disease

ArticleYear
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines.
    Recent patents on inflammation & allergy drug discovery, 2014, Volume: 8, Issue:2

    Topics: Animals; Autoimmune Diseases; Chemokines; Disease Models, Animal; Europe; Humans; Immunity, Cellular

2014

Trials

1 trial available for pioglitazone and Autoimmune Disease

ArticleYear
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.
    Diabetes & metabolism journal, 2022, Volume: 46, Issue:5

    Topics: Autoimmune Diseases; Blood Glucose; Blood Glucose Self-Monitoring; Cholesterol; Diabetes Mellitus, T

2022

Other Studies

9 other studies available for pioglitazone and Autoimmune Disease

ArticleYear
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
    Bioorganic & medicinal chemistry letters, 2015, Aug-01, Volume: 25, Issue:15

    Topics: Animals; Autoimmune Diseases; Cell Line; Cells, Cultured; Drug Discovery; HEK293 Cells; Humans; Imid

2015
Reduction in Alveolar Macrophage Size in Refractory Autoimmune Pulmonary Alveolar Proteinosis After Treatment With Pioglitazone.
    Journal of bronchology & interventional pulmonology, 2020, Volume: 27, Issue:3

    Topics: Autoimmune Diseases; Bronchoalveolar Lavage Fluid; Fibrosis; Granulocyte-Macrophage Colony-Stimulati

2020
Diabetes as First Manifestation of Autoimmune Pancreatitis.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:5

    Topics: Adrenal Cortex Hormones; Aged; Autoimmune Diseases; Diabetes Complications; Diabetes Mellitus; Dysli

2017
Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis.
    Experimental eye research, 2013, Volume: 116

    Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Female; Flow Cytometry; Humans; Hypoglycemic A

2013
Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
    Cardiovascular research, 2003, Sep-01, Volume: 59, Issue:3

    Topics: Animals; Autoimmune Diseases; Hypoglycemic Agents; Interleukin-1; Models, Animal; Myocarditis; Piogl

2003
[Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].
    Zhonghua yi xue za zhi, 2003, Dec-10, Volume: 83, Issue:23

    Topics: Animals; Autoimmune Diseases; Immunosuppressive Agents; Myocarditis; Pioglitazone; Prostaglandin D2;

2003
Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells.
    Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:6

    Topics: Animals; Autoimmune Diseases; Cells, Cultured; Dose-Response Relationship, Drug; Ligands; Myocarditi

2004
Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
    Journal of molecular and cellular cardiology, 2005, Volume: 38, Issue:2

    Topics: Animals; Autoimmune Diseases; Body Weight; Cytokines; Disease Models, Animal; Female; Hemodynamics;

2005
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:9

    Topics: Acute Disease; Animals; Autoimmune Diseases; Cardiotonic Agents; Cytokines; Gene Expression Regulati

2005